Working… Menu

Fetal Intrapartum Heart Rate FHR/ECG Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01881685
Recruitment Status : Completed
First Posted : June 20, 2013
Last Update Posted : September 18, 2019
Information provided by (Responsible Party):
Mindchild Medical Inc.

Brief Summary:
The objective of the study is to evaluate the association between certain markers in the blood of neonatal brain injury and specific Fetal Heart Rate monitoring findings using the device under study.

Condition or disease
Abnormality in Fetal Heart Rate or Rhythm

Detailed Description:

The purpose of the study is to:

  1. evaluate the association between serologic markers of neonatal brain injury and the specific FHR monitoring findings using the investigational device;
  2. investigate the relationship between selective serotonin reuptake inhibitor (SSRI) antidepressants and the QT interval of the fetal heart. Specifically, examine the potential association between maternal SSRI use and the fetal QT interval,and;
  3. develop the capacity to measure uterine contractions during labor using non-invasive electrodes that measure the electrical signal from the uterine muscle.

For this study, the investigational device will not be used to diagnose or treat as it will be used in concert with the current standard of care monitors.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 400 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Day
Official Title: Fetal Intrapartum Heart Rate FHR/ECG Study
Study Start Date : March 2013
Actual Primary Completion Date : December 2015
Actual Study Completion Date : December 2015

Primary Outcome Measures :
  1. Quantitative FHR patterns predictive of adverse neonatal outcome [ Time Frame: During Labor ]
    1)quantitative analysis of fetal heart-rate (FHR) data recorded during labor using advanced mathematical techniques, including pattern-recognition analysis using EKG stickers applied to the maternal abdomen.

Secondary Outcome Measures :
  1. Uterine contraction measurement [ Time Frame: During Labor ]
    Uterine contraction monitoring using skin surface electrodes

Biospecimen Retention:   Samples Without DNA
1) umbilical cord arterial and venous blood; 2)placenta for pathological evaluation.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women in labor who are having their fetus' heart rate monitored continuously

Inclusion Criteria:

  • Pregnant women in their third trimester and Women in labor (the progressive effacement and dilatation of the cervix) who are having their fetus' heart rate monitored continuously will form the eligible population for recruitment into our study
  • 18 years old or older
  • Women with the diagnosis of fetal intrauterine growth restriction may be included.

Exclusion Criteria:

  • Speakers of languages other than English
  • Gestational age less than 24 weeks 0 days

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01881685

Layout table for location information
United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
United States, Ohio
Summa Center for Women's Health Research
Akron, Ohio, United States, 44304
Sponsors and Collaborators
Mindchild Medical Inc.
Layout table for investigator information
Principal Investigator: Timothy Drake, MD Summa Center for Women's Health Research

Additional Information:

Layout table for additonal information
Responsible Party: Mindchild Medical Inc. Identifier: NCT01881685     History of Changes
Other Study ID Numbers: RP#12018
First Posted: June 20, 2013    Key Record Dates
Last Update Posted: September 18, 2019
Last Verified: September 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Congenital Abnormalities